HAYWARD, Calif.--(BUSINESS WIRE)--
Impax Laboratories, Inc. (NASDAQ: IPXL) announced today that its
first quarter 2012 financial results will be released before the market
opens on Tuesday, May 1, 2012 and will be available on Impax’s Web site
at www.impaxlabs.com.
The Company will host a conference call and live webcast with financial
analysts at 11:00 a.m., Eastern Time.
The live webcast will be accessible through the Investor Relations
section of the company's Web site, www.impaxlabs.com.
To access the call through a conference line, dial (877) 356-3814 (in
the U.S.) and (706) 758-0033 (international callers) beginning 10
minutes prior to the scheduled start of the call.
A replay of the conference call will be available for seven days shortly
after the call. To access the replay, dial (855) 859-2056 (in the U.S.)
and (404) 537-3406 (international callers). The access conference code
is 69137467.
About Impax Laboratories, Inc.
Impax Laboratories, Inc. is a
technology based specialty pharmaceutical company applying its
formulation expertise and drug delivery technology to the development of
controlled-release and specialty generics in addition to the development
of branded products. Impax markets its generic products through its
Global Pharmaceuticals division and markets its branded products through
the Impax Pharmaceuticals division. Additionally, where strategically
appropriate, Impax has developed marketing partnerships to fully
leverage its technology platform. Impax Laboratories is headquartered in
Hayward, California, and has a full range of capabilities in its
Hayward, Philadelphia and Taiwan facilities. For more information,
please visit the Company's Web site at: www.impaxlabs.com.
Source: Impax Laboratories, Inc.